글로벌 골관절염 통증 관리 치료 시장 – 2029년까지의 산업 동향 및 예측

시장 분석 및 규모

관절 통증은 모든 연령대의 사람들에게 흔하며 무릎의 뼈 구조와 관련이 있습니다. 관절 통증은 특정 부상이나 만성 질환의 진행으로 인해 발생합니다. 무릎 통증은 나이가 들면서 악화됩니다. 젊은 사람의 통증은 신체 활동이나 스포츠로 인한 관절의 과도한 사용과 관련이 있습니다. 노인의 경우 골관절염 과 류마티스 관절염으로 인한 관절의 마모로 인해 발생합니다. 손상된 반월판, 건염, 가성 통풍, 활액낭염, 비만 및 기타 요인은 모두 관절 통증에 영향을 미칠 수 있습니다. 질병 통제 예방 센터에 따르면 무릎 통증의 주요 원인인 관절염은 미국 성인 5,440만 명에게 영향을 미칩니다.

Data Bridge Market Research는 골관절염 통증 관리 치료 시장이 2029년까지 153억 4천만 달러 규모에 도달할 것으로 예상하며, 예측 기간 동안 CAGR은 7.25%에 이를 것으로 분석했습니다. 진통제 채택이 크게 증가하고 정부의 인식이 높아지는 것은 시장 성장을 견인하는 중요한 요인입니다.

시장 정의

골관절염은 뼈 사이의 연골을 공격하여 관절이 부어 오르고 빨갛게 변해 관절이 제대로 움직이기 어렵게 만드는 관절 질환의 한 유형입니다. 붓기, 운동 범위 감소, 팔과 다리의 부동성은 일반적인 증상이며, 특히 척추가 골관절염의 영향을 받을 때 그렇습니다.

보고 범위 및 시장 세분화

Osteoarthritic Pain Management Treatment Market Dynamics

Drivers

• The rise in the awareness by government

Increased government awareness programmes about the disease will boost market growth, as will an increase in the prevalence of osteoarthritis, an increase in the population susceptible to osteoarthritis, an increase in healthcare affordability in the US, and an increase in people's knowledge and awareness, among other factors driving the osteoarthritic pain management treatment market growth.

• The increase in the personalised medicines and collaborations from market players

The rise in personalised medicines for osteoarthritis, as well as the rise in product development collaborations, will create new opportunities for the osteoarthritic pain management treatment market during the forecast period.

Regulatory Compliance

Maintaining compliance with medical reforms and regulations raises the demand for these solutions.

• Government investments for healthcare interoperability

The increase in the funding by the federal government to drive the adoption of these solutions further influence the market. Additionally, the surge in healthcare expenditure, advancements in healthcare infrastructure, and high demand for expanded care delivery positively affect the osteoarthritic pain management treatment market.

.Restraints/Challenges

The increases in the risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment, as well as the increased commercialization of alternatives, are the major factors acting as restraints, and will further challenge the osteoarthritic pain management treatment market during the forecast period.

This osteoarthritic pain management treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the osteoarthritic pain management treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Osteoarthritic Pain Management Treatment Market

In the best-case scenario, the COVID-19 pandemic has had a significant long-term positive impact on the osteoarthritic pain management treatment market. Initially, there was a drop in the market in early 2020 as a result of lockdowns and quarantine measures. However, as the disease spread around the world, the number of laboratories, COVID-19 testing sites, and processing facilities handling SARS-CoV-2 samples, reagents, and vaccines increased expon The COVID-19 outbreak is expected to have a minor impact on the market for osteoarthritis therapeutics. Corticosteroids are one of the drugs that have seen a decrease in use. Although there is no evidence that corticosteroid injections significantly increase the risk of infection, there may be a reduction in immune response for a few weeks after the procedure. While the risk is extremely low, it must be considered when deciding whether or not to proceed with the procedure. It should also be noted that the WHO suggested avoiding systemic corticosteroids in one of its guidelines for the management of severe acute respiratory infection in patients with coronavirus.entially.

.Recent Development

• Voltaren was introduced in the United States by GlaxoSmithKline Plc (UK) in 2020.
• Horizon Therapeutics Plc (Ireland) expanded its presence in the United States in 2020.
• Kitov Pharma Ltd. (Israel) signed an agreement with Coeptis Pharmaceuticals in 2019, which aided in the efficient distribution and commercialization of Consensi.
• Atnahs opened a sales office in Dubai, UAE, in 2018.
• Flexion Therapeutics, Inc. (US) received FDA approval for ZILRETTA in 2017.

Global Osteoarthritic Pain Management Treatment Market Scope

The osteoarthritic pain management treatment market is segmented on the basis type, drug, diagnosis, treatment and end-users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Hip osteoarthritis
• Spinal osteoarthritis.

On the basis of type, the osteoarthritic pain management treatment market is segmented into hip osteoarthritis and spinal osteoarthritis.

Drug                                                                               

• NSAIDs
• Corticosteroids
• Hyaluronic acid injection
• Other drugs

Based on drug, the osteoarthritic pain management treatment market is segmented into NSAIDs, corticosteroids, hyaluronic acid injection and other drugs.

Diagnosis

• Imaging
• Joint fluid analysis

Based on diagnosis, the osteoarthritic pain management treatment market is segmented into imaging and joint fluid analysis.

Treatment

• Medication
• Surgery
• therapy

Based on treatment, the osteoarthritic pain management treatment market is segmented into medication, surgery and therapy.

Distribution channel

• Hospitals
• Medical institutes

Osteoarthritic pain management treatment is also segmented on the basis of distribution channel into hospitals and medical institutes.

Osteoarthritic Pain Management Treatment Market Regional Analysis/Insights

The osteoarthritic pain management treatment market is analysed and market size insights and trends are provided by country, type, drug, diagnosis, treatment and end-users as referenced above.

The countries covered in the osteoarthritic pain management treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the osteoarthritic pain management treatment market due to changing lifestyles and rising healthcare costs. a rise in research funding availability, a large patient population, rising healthcare expenditures, a well-developed healthcare sector, and government support for R&D in this region Asia-Pacific is expected to be the fastest growing region in terms of osteoarthritic pain management treatment due to the large patient population and the presence of a large market opportunity.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.   

의료 인프라 성장 설치 기반 및 신기술 침투

골관절염 통증 관리 치료 시장은 또한 모든 국가에 대한 자세한 시장 분석을 제공합니다. 자본 장비에 대한 의료 지출 증가, 골관절염 통증 관리 치료 시장을 위한 다양한 종류의 제품 설치 기반, 수명선 곡선을 사용한 기술의 영향, 의료 규제 시나리오의 변화 및 골관절염 통증 관리 치료 시장에 미치는 영향. 이 데이터는 2010-2020년의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 골관절염 통증 관리 치료 시장 점유율 분석

골관절염 통증 관리 치료 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 골관절염 통증 관리 치료 시장과 관련된 회사의 초점에만 관련이 있습니다.

골관절염 통증 관리 치료 시장에서 운영되는 주요 업체 중 일부는 다음과 같습니다.

• 사노피(프랑스)
• Horizon Therapeutics PLC(아일랜드)
• 존슨앤존슨(미국)
• GlaxoSmithKline PLC(영국),
• Bayer AG(독일)
• 애벗(미국)
• 파이저 주식회사(미국)
• 엘리 릴리(미국)
• 아니카 테라퓨틱스 주식회사(미국)
• 노바티스 AG(스위스)
• Ferring Pharmaceuticals (스위스)
• 바이오벤투스(미국)
• Zimmer Biomet Holdings, Inc. (미국)
• Fidia Farmaceutici 스파 (이탈리아)
• 플렉션 테라퓨틱스(Flexion Therapeutics, Inc.) (미국)
• Pharmed Limited(인도)
• Virchow Biotech(인도),

SKU-26326